Carfilzomib and Belatacept for Desensitization

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Carfilzomib and Belatacept for Desensitization	Highly Sensitized Prospective Kidney Transplant Recipients	Active, not recruiting	Phase 1 / Phase 2	2026-04-08		NCT05017545

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bristol-Myers Squibb	422
Immune Tolerance Network (ITN)	7
National Institute of Allergy and Infectious Diseases (NIAID)	402
PPD Development, LP	27
Rho Federal Systems Division, Inc.	12

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Duke Transplant Center, Duke University Medical Center	Durham	United States	1

Clinical trials